Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bee Venom As Immunomodulator and Its Effect on Chronic Kidney Disease-Mineral Bone Disorders in Hemodialysis Patients: a Prospective Randomized Controlled Trial

NCT06901102 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT06901102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06901102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bee Venom As Immunomodulator and Its Effect on Chronic Kidney Disease-Mineral Bone Disorders in Hemodialysis Patients: a Prospective Randomized Controlled Trial
Lead sponsor
Mansoura University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
April 10, 2025
Completion date
October 20, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bee venom, chronic kidney disease, hemodialysis